{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:27Z","timestamp":1787502987551,"version":"build-2736575974"},"reference-count":60,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,3,18]],"date-time":"2004-03-18T00:00:00Z","timestamp":1079568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Skip metastasis to mediastinal lymph nodes is a prognostic factor for patients with nonsmall cell lung carcinoma (NSCLC). Little is known about the biologic behavior of tumors with noncontinuous spread to the mediastinal lymph nodes. In patients with pN2 skip metastases, micrometastases to N1 lymph nodes, which only mimic skip metastases, have not been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      In a retrospective study, the authors analyzed the primary tumor specimens from 45 patients with pN2 NSCLC (18 patients had squamous cell carcinomas, 23 had adenocarcinomas, and 4 had large cell carcinomas). They immunohistochemically evaluated the expression of p21, p53, MUC\u20101, Bcl\u20102, c\u2010ErbB\u20102, and E\u2010cadherin. Survival rates and biomarker expression levels were compared between patients with pN2 disease and infiltration of N1 lymph nodes (without skip metastasis [\n                      <jats:italic>n<\/jats:italic>\n                      = 28]) and patients with pN2 disease without N1 infiltration (with skip metastasis [\n                      <jats:italic>n<\/jats:italic>\n                      = 17]). To evaluate micrometastasis in the pN1 lymph nodes of 17 patients with skip metastases, lymph nodes were stained using the anticytokeratin antibody, AE1\/AE3.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The 5\u2010year survival rate of patients with skip metastases was 41%, compared with 14% for patients without skip metastases (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.019). In a multivariate analysis, the incidence of skip metastases did not vary significantly according to gender, age, histology, pT status, or cM status. Three skip\u2010positive patients (17.6%) had micrometastatic tumor involvement of pN1 lymph nodes. After adding these patients to the group of patients without skip metastases, there was still a significant difference in survival between the two groups. p53, MUC\u20101, c\u2010ErbB\u20102, and E\u2010cadherin expression levels in primary tumor specimens were not significantly different in patients with continuous metastasis and patients with skip metastases. Patients with skip metastases expressed lower levels of p21 (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.026), whereas Bcl\u20102 expression levels were considerably higher (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.019) compared with the corresponding levels in patients without skip metastases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>\n                      Patients with NSCLC and pN2 skip metastases have a more favorable prognosis than do patients with pN2 disease without skip metastases. Tumor specimens from these patients exhibit elevated expression of the antiapoptosis gene\n                      <jats:italic>BCL2<\/jats:italic>\n                      and lower expression levels of p21 relative to patients with pN2 disease without skip metastases. Micrometastases occurred in 3 of 17 (17.6%) patients with pN2 disease and skip metastases diagnosed by routine histopathology. Cancer 2004. \u00a9 2004 American Cancer Society.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cncr.20165","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T09:41:02Z","timestamp":1081849262000},"page":"1909-1917","source":"Crossref","is-referenced-by-count":26,"title":["Skip metastasis in nonsmall cell lung carcinoma"],"prefix":"10.1002","volume":"100","author":[{"given":"Klaus L.","family":"Prenzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan E.","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan P.","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Sinning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Gutschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans P.","family":"Dienes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf H.","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,3,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-198309000-00015"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(97)00314-7"},{"key":"e_1_2_5_4_2","first-page":"244","volume-title":"Diagnosis and treatment of lung cancer","author":"Detterbeck FC","year":"2001"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70217-5"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(97)00535-3"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(94)91335-8"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1013939"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(90)90666-T"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930570302"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.10219"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(96)00470-5"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200007000-00016"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690152"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-5002(01)00462-7"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1994.1063"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/366701a0"},{"key":"e_1_2_5_18_2","first-page":"1831","article-title":"p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung","volume":"3","author":"Komiya T","year":"1997","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.147"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.30183"},{"key":"e_1_2_5_21_2","first-page":"1125","article-title":"Predictive survival markers in patients with surgically resected non\u2010small cell lung carcinoma","volume":"6","author":"Moldvay J","year":"2000","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_22_2","first-page":"915","article-title":"Bcl\u20102 and p53 protein expression in non\u2010small cell lung cancers: correlation with survival time","volume":"2","author":"Ohsaki Y","year":"1996","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90062-9"},{"key":"e_1_2_5_24_2","first-page":"135","article-title":"Altered cadherin and catenin complexes in the Barrett's esophagus\u2010dysplasia\u2010adenocarcinoma sequence: correlation with disease progression and dedifferentiation","volume":"152","author":"Bailey T","year":"1998","journal-title":"Am J Pathol."},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70218-X"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270412"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1649::AID-CNCR9>3.0.CO;2-5"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.4.9703099"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.51.9.667"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.6.1710"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<133::AID-IJC6>3.0.CO;2-U"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00466.x"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(97)70320-9"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)64717-0"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1159::AID-CNCR9>3.0.CO;2-K"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00311501"},{"key":"e_1_2_5_37_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5223(19)34555-6","article-title":"Direct lymphatic drainage of lung segments to mediastinal nodes","volume":"97","author":"Riquet M","year":"1989","journal-title":"J Thorac Cardiovasc Surg."},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-4975(95)01012-2"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.19"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(97)70041-2"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.7.4.565"},{"key":"e_1_2_5_42_2","first-page":"2240","article-title":"Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma","volume":"46","author":"Masaki Y","year":"1999","journal-title":"Hepatogastroenterology."},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i3.404"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-7404(94)90006-X"},{"key":"e_1_2_5_46_2","first-page":"51","article-title":"A prognostic model of recurrence and death in Stage I non\u2010small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression","volume":"55","author":"Harpole DH","year":"1995","journal-title":"Cancer Res."},{"key":"e_1_2_5_47_2","first-page":"3819","article-title":"Non\u2010small cell lung cancer: c\u2010erbB\u20102 overexpression correlates with low angiogenesis and poor prognosis","volume":"16","author":"Giatromanolaki A","year":"1996","journal-title":"Anticancer Res."},{"key":"e_1_2_5_48_2","first-page":"3427","article-title":"Wild\u2010type p53\u2010triggered apoptosis is inhibited by bcl\u20102 in a v\u2010myc\u2010induced T\u2010cell lymphoma line","volume":"8","author":"Wang Y","year":"1993","journal-title":"Oncogene."},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.4.879.879"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711770206"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309023291003"},{"key":"e_1_2_5_52_2","first-page":"915","article-title":"bcl\u20102 and p53 protein expression in non\u2010small cell lung cancers: correlation with survival time","volume":"2","author":"Ohsaki Y","year":"1996","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_53_2","first-page":"4055","article-title":"Prognostic significance of p53 alterations in patients with non\u2010small cell lung cancer: a meta\u2010analysis","volume":"6","author":"Mitsudomi T","year":"2000","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.448"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90499-G"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"e_1_2_5_57_2","first-page":"1831","article-title":"p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung","volume":"3","author":"Komija T","year":"1997","journal-title":"Clin Cancer Res."},{"key":"e_1_2_5_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90214-W"},{"key":"e_1_2_5_59_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411535"},{"key":"e_1_2_5_60_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-003-0074-y"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.16.2981"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.20165","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.20165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:49:42Z","timestamp":1760266182000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.20165"}},"subtitle":["Predictive markers and isolated tumor cells in N1 lymph nodes"],"short-title":[],"issued":{"date-parts":[[2004,3,18]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1002\/cncr.20165"],"URL":"https:\/\/doi.org\/10.1002\/cncr.20165","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,18]]}}}